The funding came from investors within the spine industry and the Genesis Innovation Group, according to a Nov. 8 news release. Happe Spine plans to use the money to launch an implant for spinal fusions.
Happe Spine has a proprietary material platform, HydroxyApatite Porous Peek, for implants. The material’s allograft-like qualities are designed to help improve clinical outcomes in interbody spinal fusions.
